{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:42:36Z","timestamp":1791207756615,"version":"4.1.0"},"reference-count":183,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["FSSM-2022-0004"],"award-info":[{"award-number":["FSSM-2022-0004"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>In recent decades, there has been an increased interest in the development of intranasal delivery systems for active pharmaceutical ingredients (APIs) not only for treating local nasal diseases but also for treating systemic diseases, central nervous system (CNS) disorders, and vaccine delivery. The nasal cavity possesses a unique set of anatomical characteristics for delivering active pharmaceutical ingredients, but there are several limitations that recent research in the field of the intranasal administration of APIs aims to overcome. For the effective delivery of nasal preparations, active pharmaceutical ingredients are incorporated into various micro- and nanosystems. Some of the most commonly encountered API delivery systems in the scientific literature include liposomal systems, polymer particles with mucoadhesive properties, in situ gels, nano- and microemulsions, and solid lipid particles. This article provides a review of research on the development of nasal preparations for treating local nasal cavity diseases (in particular, for antibiotic delivery), systemic diseases (analgesics, drugs for cardiovascular diseases, antiviral and antiemetic drugs), CNS disorders (Alzheimer\u2019s disease, Parkinson\u2019s disease, epilepsy, schizophrenia, depression), and vaccine delivery. The literature data show that active research is underway to reformulate drugs of various pharmacotherapeutic groups into a nasal form.<\/jats:p>","DOI":"10.3390\/ph17091180","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T03:04:18Z","timestamp":1725851058000},"page":"1180","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems"],"prefix":"10.3390","volume":"17","author":[{"given":"Ruslan","family":"Safarov","sequence":"first","affiliation":[{"name":"Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Fedotova","sequence":"additional","affiliation":[{"name":"Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Uvarova","sequence":"additional","affiliation":[{"name":"Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Gordienko","sequence":"additional","affiliation":[{"name":"Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7806-1426","authenticated-orcid":false,"given":"Natalia","family":"Menshutina","sequence":"additional","affiliation":[{"name":"Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"key":"ref_1","unstructured":"William, H.F. (1991). Neurologic Agents for Nasal Administration to the Brain. (9,107,947), WO Patent, Available online: https:\/\/patents.google.com\/patent\/WO1991007947A1\/en?q=(Neurologic+Agents+for+Nasal+Administration+to+the+Brain)&inventor=Frey+William&oq=Neurologic+Agents+for+Nasal+Administration+to+the+Brain++Frey+William."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal Drug Delivery: Opportunities and Toxicologic Challenges during Drug Development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Crowe, T.P., and Hsu, W.H. (2022). Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14030629"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"118813","DOI":"10.1016\/j.ijpharm.2019.118813","article-title":"Nasal Route for Vaccine and Drug Delivery: Features and Current Opportunities","volume":"572","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2012.03.003","article-title":"Intranasal Drug Delivery: An Efficient and Non-Invasive Route for Systemic Administration: Focus on Opioids","volume":"134","author":"Buenestado","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/molecules14093754","article-title":"Nasal Delivery of High Molecular Weight Drugs","volume":"14","author":"Ozsoy","year":"2009","journal-title":"Molecules"},{"key":"ref_7","first-page":"194","article-title":"A Review on Factors Affecting the Design of Nasal Drug Delivery System","volume":"3","author":"Dhakar","year":"2011","journal-title":"Int. J. Drug Deliv."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hussein, N.R., Omer, H.K., Elhissi, A.M.A., and Ahmed, W. (2020). Chapter 15\u2014Advances in Nasal Drug Delivery Systems. Advances in Medical and Surgical Engineering, Academic Press.","DOI":"10.1016\/B978-0-12-819712-7.00015-2"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"120994","DOI":"10.1016\/j.ijpharm.2021.120994","article-title":"Progress in Nasal Drug Delivery Systems","volume":"607","author":"Laffleur","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.17650\/1726-9784-2021-20-1-33-41","article-title":"Liposomes as a targeted delivery system of drugs (review)","volume":"20","author":"Gorbik","year":"2021","journal-title":"Russ. J. Biother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11094-009-0271-6","article-title":"Mucoadhesive drug delivery systems (review)","volume":"43","author":"Kharenko","year":"2009","journal-title":"Pharm. Chem. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.33380\/2305-2066-2021-10-4-54-63","article-title":"In situ Intranasal Delivery Systems: Application Prospects and Main Pharmaceutical Aspects of Development (Review)","volume":"10","author":"Bakhrushina","year":"2021","journal-title":"Drug Dev. Regist."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A Brief Review on Solid Lipid Nanoparticles: Part and Parcel of Contemporary Drug Delivery Systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112905","DOI":"10.1016\/j.ejmech.2020.112905","article-title":"Non-Invasive Intranasal Administration Route Directly to the Brain Using Dendrimer Nanoplatforms: An Opportunity to Develop New CNS Drugs","volume":"209","author":"Mignani","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Liva, G.A., Karatzanis, A.D., and Prokopakis, E.P. (2021). Review of Rhinitis: Classification, Types, Pathophysiology. J. Clin. Med., 10.","DOI":"10.3390\/jcm10143183"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/pai.13164","article-title":"Update on Rhinitis and Rhinosinusitis","volume":"31","author":"Zicari","year":"2020","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/all.14629","article-title":"Management of Patients with Chronic Rhinosinusitis during the COVID-19 Pandemic\u2014An EAACI Position Paper","volume":"76","author":"Klimek","year":"2021","journal-title":"Allergy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal Drug Delivery Devices: Characteristics and Performance in a Clinical Perspective\u2014A Review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103887","DOI":"10.1016\/j.jddst.2022.103887","article-title":"Nasal Route for Antibiotics Delivery: Advances, Challenges and Future Opportunities Applying the Quality by Design Concepts","volume":"77","author":"Mardikasari","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Homayun, B., Lin, X., and Choi, H.-J. (2019). Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11030129"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhsa.2014.01.021","article-title":"Adverse Effects of Common Oral Antibiotics","volume":"39","author":"Richardson","year":"2014","journal-title":"J. Hand Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.jaci.2022.02.004","article-title":"Is There a Role for Antibiotics in the Treatment of Chronic Rhinosinusitis?","volume":"149","author":"Smith","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/alr.20106","article-title":"Microbiological Outcomes Following Mupirocin Nasal Washes for Symptomatic, Staphylococcus Aureus\u2013Positive Chronic Rhinosinusitis Following Endoscopic Sinus Surgery","volume":"2","author":"Wormald","year":"2012","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/alr.21076","article-title":"The Effect of Intraoperative Mupirocin Irrigation on Staphylococcus Aureus within the Maxillary Sinus","volume":"3","author":"Seiberling","year":"2013","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102604","DOI":"10.1016\/j.amjoto.2020.102604","article-title":"Tolerability and Effectiveness of Povidone-Iodine or Mupirocin versus Saline Sinus Irrigations for Chronic Rhinosinusitis","volume":"41","author":"Lee","year":"2020","journal-title":"Am. J. Otolaryngol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13756-021-01043-1","article-title":"Efficacy of Mupirocin, Neomycin and Octenidine for Nasal Staphylococcus Aureus Decolonisation: A Retrospective Cohort Study","volume":"11","author":"Allport","year":"2022","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jcf.2014.02.006","article-title":"Efficacy and Tolerability of a New Nasal Spray Formulation Containing Hyaluronate and Tobramycin in Cystic Fibrosis Patients with Bacterial Rhinosinusitis","volume":"13","author":"Alicandro","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.anorl.2015.03.008","article-title":"Efficacy of Tobramycin Aerosol in Nasal Polyposis","volume":"132","author":"Bonfils","year":"2015","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/1012-5574.199411","article-title":"The Effect of Topical Vancomycin on the Recurrent Postoperative Sinonasal Polyposis: A Triple-Blinded Randomized Controlled Trial","volume":"33","author":"Jahanshahi","year":"2017","journal-title":"Egypt. J. Otolaryngol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.otorri.2017.06.008","article-title":"On Ciprofloxacin Concentration in Chronic Rhinosinusitis","volume":"69","author":"Figueirinhas","year":"2018","journal-title":"Acta Otorrinolaringol. Esp."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"101705","DOI":"10.1016\/j.jddst.2020.101705","article-title":"Ciprofloxacin Loaded o\/w Microemulsion against Staphylococcus Aureus. Analytical and Biological Studies for Topical and Intranasal Administration","volume":"57","author":"Volpe","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejps.2016.10.033","article-title":"Intranasal Delivery of Ciprofloxacin to Rats: A Topical Approach Using a Thermoreversible in Situ Gel","volume":"97","author":"Sousa","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1007\/s11095-017-2232-1","article-title":"Intranasal Delivery of Topically-Acting Levofloxacin to Rats: A Proof-of-Concept Pharmacokinetic Study","volume":"34","author":"Sousa","year":"2017","journal-title":"Pharm. Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ghadiri, M., Young, P.M., and Traini, D. (2019). Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11030113"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1526-4637.2006.00270.x","article-title":"The Treatment of Breakthrough Pain","volume":"8","author":"McCarberg","year":"2007","journal-title":"Pain Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1399-6576.2008.01608.x","article-title":"A Controlled Comparison between Single Doses of Intravenous and Intramuscular Morphine with Respect to Analgesic Effects and Patient Safety","volume":"52","author":"Tveita","year":"2008","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.301.1.391","article-title":"Intranasal Delivery of Morphine","volume":"301","author":"Illum","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/ecp.12.69","article-title":"Fentanyl Pectin Nasal Spray: A Novel Intranasal Delivery Method for the Treatment of Breakthrough Cancer Pain","volume":"6","author":"Bulloch","year":"2013","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(00)00499-3","article-title":"Intranasal Absorption of Buprenorphine\u2014In Vivo Bioavailability Study in Sheep","volume":"205","author":"Lindhardt","year":"2000","journal-title":"Int. J. Pharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(01)00591-9","article-title":"Intranasal Bioavailability of Buprenorphine in Rabbit Correlated to Sheep and Man","volume":"217","author":"Lindhardt","year":"2001","journal-title":"Int. J. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Xhakaza, S.P., Khoza, L.J., Haripershad, A.M., Ghazi, T., Dhani, S., Mutsimhu, C., Molopa, M.J., Madurai, N.P., Madurai, L., and Singh, S.D. (2021). Alterations in Neurotransmitter Levels and Transcription Factor Expression Following Intranasal Buprenorphine Administration. Biomed. Pharmacother., 138.","DOI":"10.1016\/j.biopha.2021.111515"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpsychires.2019.02.003","article-title":"Brain Penetration of Ketamine: Intranasal Delivery VS Parenteral Routes of Administraion","volume":"112","author":"Naidoo","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5847\/wjem.j.1920-8642.2016.01.003","article-title":"Intranasal Ketamine for the Treatment of Patients with Acute Pain in the Emergency Department","volume":"7","author":"Shrestha","year":"2016","journal-title":"World J. Emerg. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.31351\/vol28iss2pp95-104","article-title":"Formulation and evaluation of sustained release sumatriptan mucoadhesive intranasal in-situ gel","volume":"28","author":"Alkufi","year":"2019","journal-title":"Iraqi J. Pharm. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ribeiro, L.N.M., Rodrigues da Silva, G.H., Couto, V.M., Castro, S.R., Breitkreitz, M.C., Martinez, C.S., Igart\u00faa, D.E., Prieto, M.J., and de Paula, E. (2020). Functional Hybrid Nanoemulsions for Sumatriptan Intranasal Delivery. Front. Chem., 8.","DOI":"10.3389\/fchem.2020.589503"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1517\/17425247.2015.1060959","article-title":"A Novel Intranasal Breath-Powered Delivery System for Sumatriptan: A Review of Technology and Clinical Application of the Investigational Product AVP-825 in the Treatment of Migraine","volume":"12","author":"Cady","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/head.12167","article-title":"Improved Pharmacokinetics of Sumatriptan with Breath PoweredTM Nasal Delivery of Sumatriptan Powder","volume":"53","author":"Obaidi","year":"2013","journal-title":"Headache J. Head Face Pain"},{"key":"ref_48","first-page":"478","article-title":"Formulation and Evaluation of Ion-Sensitive in-Situ Nasal Gel of Zolmitriptan","volume":"7","author":"Patil","year":"2015","journal-title":"Int. J. Pharm. Pharm. Sci"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/2211738510666220303160414","article-title":"Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery","volume":"10","author":"Jha","year":"2022","journal-title":"Pharm. Nanotechnol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0304-3959(03)00318-X","article-title":"Initial Pharmacokinetic, Safety and Efficacy Evaluation of Nasal Morphine Gluconate for Breakthrough Pain in Cancer Patients","volume":"106","author":"Fitzgibbon","year":"2003","journal-title":"Pain"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1526-4637.2007.00300.x","article-title":"Analgesic Efficacy and Safety of Morphine-Chitosan Nasal Solution in Patients with Moderate to Severe Pain Following Orthopedic Surgery","volume":"9","author":"Stoker","year":"2008","journal-title":"Pain Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5055\/jom.2010.0001","article-title":"Pharmacokinetics of Intranasal Fentanyl Spray in Patients with Cancer and Breakthrough Pain","volume":"6","author":"Kaasa","year":"2010","journal-title":"J. Opioid Manag."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10611860500246217","article-title":"Intranasal Mucoadhesive Microemulsions of Zolmitriptan: Preliminary Studies on Brain-Targeting","volume":"13","author":"Vyas","year":"2005","journal-title":"J. Drug Target."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11095-009-0041-x","article-title":"Micellar Nanocarriers: Potential Nose-to-Brain Delivery of Zolmitriptan as Novel Migraine Therapy","volume":"27","author":"Jain","year":"2010","journal-title":"Pharm. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00044011-200525030-00006","article-title":"Bioequivalence and Rapid Absorption of Zolmitriptan Nasal Spray Compared with Oral Tablets in Healthy Japanese Subjects","volume":"25","author":"Uemura","year":"2005","journal-title":"Clin. Drug Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00126839-200506030-00002","article-title":"Distribution of Zolmitriptan into the CNS in Healthy Volunteers","volume":"6","author":"Wall","year":"2005","journal-title":"Drugs R D"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/713840323","article-title":"Sodium Alginate Microspheres of Metoprolol Tartrate for Intranasal Systemic Delivery: Development and Evaluation","volume":"10","author":"Rajinikanth","year":"2003","journal-title":"Drug Deliv."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4103\/0250-474X.110608","article-title":"In Situ Gel of Metoprolol Tartrate: Physicochemical Characterization, In Vitro Diffusion and Histological Studies","volume":"74","author":"Khan","year":"2012","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1248\/yakushi.121.355","article-title":"Evaluation of the Method for Nifedipine Administration for a Rapid Onset of Clinical Effect: A clinical study in normal volunteers","volume":"121","author":"Kubota","year":"2001","journal-title":"Yakugaku Zasshi"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3109\/10717544.2015.1013587","article-title":"Nanotransfersomes of Carvedilol for Intranasal Delivery: Formulation, Characterization and in Vivo Evaluation","volume":"23","author":"Aboud","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/10611861003663523","article-title":"Mucoadhesive Chitosan Microspheres of Carvedilol for Nasal Administration","volume":"18","author":"Patil","year":"2010","journal-title":"J. Drug Target."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/02652040802456726","article-title":"Development, Optimization and in Vitro Evaluation of Alginate Mucoadhesive Microspheres of Carvedilol for Nasal Delivery","volume":"26","author":"Patil","year":"2009","journal-title":"J. Microencapsul."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1208\/s12249-012-9896-y","article-title":"Nanosuspension Based In Situ Gelling Nasal Spray of Carvedilol: Development, In Vitro and In Vivo Characterization","volume":"14","author":"Saindane","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"ref_64","first-page":"1363","article-title":"Brain Targeted Intra Nasal Acyclovir Lipid Nanoparticles; in-Vitro Characterization and in-Vivo Biodistribution Studies","volume":"35","author":"Selvaraj","year":"2022","journal-title":"Pak. J. Pharm. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/10717540802035251","article-title":"Acyclovir Liposomes for Intranasal Systemic Delivery: Development and Pharmacokinetics Evaluation","volume":"15","author":"Alsarra","year":"2008","journal-title":"Drug Deliv."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijpharm.2010.05.020","article-title":"Intranasal Delivery of Zidovudine by PLA and PLA\u2013PEG Blend Nanoparticles","volume":"395","author":"Mainardes","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kumar, A., Zhou, L., Godse, S., Sinha, N., Ma, D., Parmar, K., and Kumar, S. (2023). Intranasal Delivery of Darunavir Improves Brain Drug Concentrations in Mice for Effective HIV Treatment. Biochem. Biophys. Rep., 33.","DOI":"10.1016\/j.bbrep.2022.101408"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejps.2007.08.006","article-title":"Enhanced Bioavailability of Metoclopramide HCl by Intranasal Administration of a Mucoadhesive in Situ Gel with Modulated Rheological and Mucociliary Transport Properties","volume":"32","author":"Zaki","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_69","first-page":"80","article-title":"Development and Evaluation of Ion-Dependent in-Situ Nasal Gelling Systems of Metoclopramide Hydrochloride as an Antimigraine Model Drug","volume":"1","author":"Viram","year":"2012","journal-title":"Int. J. Latest Res. Sci. Technol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"353","DOI":"10.31024\/ajpp.2018.4.3.18","article-title":"Design and Evaluation of Nasal Delivery of Metoclopramide Hydrochloride Microspheres","volume":"4","author":"Dass","year":"2018","journal-title":"Asian J. Pharm. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s10856-012-4702-7","article-title":"Solid Lipid Nanoparticles of Ondansetron HCl for Intranasal Delivery: Development, Optimization and Evaluation","volume":"23","author":"Joshi","year":"2012","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.colsurfb.2014.06.037","article-title":"Surface Engineered Nanostructured Lipid Carriers for Efficient Nose to Brain Delivery of Ondansetron HCl Using Delonix regia Gum as a Natural Mucoadhesive Polymer","volume":"122","author":"Devkar","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_73","first-page":"075","article-title":"HPMC K15M and Carbopol 940 Mediated Fabrication of Ondansetron Hydrochloride Intranasal Mucoadhesive Microspheres","volume":"8","author":"Dhawale","year":"2018","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain Barrier: From Physiology to Disease and Back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneumeth.2018.10.015","article-title":"Drug Targeting Strategies into the Brain for Treating Neurological Diseases","volume":"311","author":"Barnabas","year":"2019","journal-title":"J. Neurosci. Methods"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"G\u00e4nger, S., and Schindowski, K. (2018). Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10030116"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"103932","DOI":"10.1016\/j.jddst.2022.103932","article-title":"Emerging Nanoformulations for Drug Targeting to Brain through Intranasal Delivery: A Comprehensive Review","volume":"78","author":"Bahadur","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2000076","DOI":"10.1002\/adtp.202000076","article-title":"Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer\u2019s Disease","volume":"4","author":"Rabiee","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molliq.2018.01.123","article-title":"Optimization of Rivastigmine Nanoemulsion for Enhanced Brain Delivery: In-Vivo and Toxicity Evaluation","volume":"255","author":"Haider","year":"2018","journal-title":"J. Mol. Liq."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11095-017-2279-z","article-title":"Formulation and In-Vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting","volume":"35","author":"Shah","year":"2018","journal-title":"Pharm. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3109\/10717544.2013.878857","article-title":"Nose to Brain Microemulsion-Based Drug Delivery System of Rivastigmine: Formulation and Ex-Vivo Characterization","volume":"22","author":"Shah","year":"2015","journal-title":"Drug Deliv."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.colsurfb.2017.08.031","article-title":"Thermosensitive in Situ Nanocomposite of Rivastigmine Hydrogen Tartrate as an Intranasal Delivery System: Development, Characterization, Ex Vivo Permeation and Cellular Studies","volume":"159","author":"Salatin","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1002\/jps.24557","article-title":"Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer\u2019s Disease: Optimization, Biological Efficacy, and Potential Toxicity","volume":"104","author":"Elnaggar","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/1061186X.2012.747529","article-title":"Preparation, Characterization, in Vivo and Biochemical Evaluation of Brain Targeted Piperine Solid Lipid Nanoparticles in an Experimentally Induced Alzheimer\u2019s Disease Model","volume":"21","author":"Yusuf","year":"2013","journal-title":"J. Drug Target."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2017.11.040","article-title":"Nose-to-Brain Delivery of Insulin Enhanced by a Nanogel Carrier","volume":"270","author":"Picone","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1166\/jbn.2019.2724","article-title":"The Trigeminal Pathway Dominates the Nose-to-Brain Transportation of Intact Polymeric Nanoparticles: Evidence from Aggregation-Caused Quenching Probes","volume":"15","author":"Li","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_87","first-page":"19","article-title":"Formulation and Evaluation of Curcumin Loaded Transferosomal Nasal In-Situ Gel for Alzheimer\u2019s Disease","volume":"6","author":"Murali","year":"2019","journal-title":"Res. Rev. J. Drug Formul. Dev. Prod."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/10717544.2016.1233593","article-title":"Docosahexaenoic Acid\u2013Mediated, Targeted and Sustained Brain Delivery of Curcumin Microemulsion","volume":"24","author":"Shinde","year":"2017","journal-title":"Drug Deliv."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","article-title":"Donepezil Nanosuspension Intended for Nose to Brain Targeting: In Vitro and in Vivo Safety Evaluation","volume":"67","author":"Bhavna","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/DDDT.S93937","article-title":"Preparation, Characterization, and in Vivo Evaluation of Intranasally Administered Liposomal Formulation of Donepezil","volume":"10","author":"Ullah","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2478\/acph-2020-0032","article-title":"Preparation, Characterization, and in Vivo Pharmacokinetics of Thermosensitive s Nasal Gel of Donepezil Hydrochloride","volume":"70","author":"Gu","year":"2020","journal-title":"Acta Pharm."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Al Harthi, S., Alavi, S.E., Radwan, M.A., El Khatib, M.M., and AlSarra, I.A. (2019). Nasal Delivery of Donepezil HCl-Loaded Hydrogels for the Treatment of Alzheimer\u2019s Disease. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-46032-y"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1871527317666180104122347","article-title":"Development of a Nasal Donepezil-Loaded Microemulsion for the Treatment of Alzheimer\u2019s Disease: In Vitro and Ex Vivo Characterization","volume":"17","author":"Espinoza","year":"2018","journal-title":"CNS Neurol. Disord.-Drug Targets- CNS Neurol. Disord."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.colsurfb.2016.08.011","article-title":"Fabrication of an Ionic-Sensitive in Situ Gel Loaded with Resveratrol Nanosuspensions Intended for Direct Nose-to-Brain Delivery","volume":"147","author":"Hao","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejpb.2018.02.010","article-title":"Brain Targeting of Resveratrol by Nasal Administration of Chitosan-Coated Lipid Microparticles","volume":"127","author":"Trotta","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.maturitas.2013.05.019","article-title":"Drug Development in Parkinson\u2019s Disease: From Emerging Molecules to Innovative Drug Delivery Systems","volume":"76","author":"Garbayo","year":"2013","journal-title":"Maturitas"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/WNL.58.suppl_1.S19","article-title":"Levodopa Strengths and Weaknesses","volume":"58","author":"Jankovic","year":"2002","journal-title":"Neurology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.nano.2018.08.004","article-title":"Pharmacokinetics and Pharmacodynamics of Intranasally Administered Selegiline Nanoparticles with Improved Brain Delivery in Parkinson\u2019s Disease","volume":"14","author":"Sridhar","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"435101","DOI":"10.1088\/0957-4484\/27\/43\/435101","article-title":"Design Expert\u00ae Supported Optimization and Predictive Analysis of Selegiline Nanoemulsion via the Olfactory Region with Enhanced Behavioural Performance in Parkinson\u2019s Disease","volume":"27","author":"Kumar","year":"2016","journal-title":"Nanotechnology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","article-title":"Bromocriptine Loaded Chitosan Nanoparticles Intended for Direct Nose to Brain Delivery: Pharmacodynamic, Pharmacokinetic and Scintigraphy Study in Mice Model","volume":"48","author":"Md","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_101","first-page":"1645","article-title":"Formulation, optimization and evaluation of rasagiline mesylate in situ nasal gel","volume":"8","author":"Kola","year":"2018","journal-title":"Indo Am. J. Pharm. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/10717544.2014.907372","article-title":"Brain Targeted Nanoparticulate Drug Delivery System of Rasagiline via Intranasal Route","volume":"23","author":"Mittal","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/10826076.2017.1343735","article-title":"Rasagiline-Encapsulated Chitosan-Coated PLGA Nanoparticles Targeted to the Brain in the Treatment of Parkinson\u2019s Disease","volume":"40","author":"Ahmad","year":"2017","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Xie, H., Li, L., Sun, Y., Wang, Y., Gao, S., Tian, Y., Ma, X., Guo, C., Bo, F., and Zhang, L. (2019). An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel. Nanomaterials, 9.","DOI":"10.3390\/nano9020147"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejpb.2015.05.019","article-title":"Intranasal Delivery of Dopamine to the Striatum Using Glycol Chitosan\/Sulfobutylether-\u03b2-Cyclodextrin Based Nanoparticles","volume":"94","author":"Trapani","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/10717544.2019.1636420","article-title":"Brain-Targeted Intranasal Delivery of Dopamine with Borneol and Lactoferrin Co-Modified Nanoparticles for Treating Parkinson\u2019s Disease","volume":"26","author":"Tang","year":"2019","journal-title":"Drug Deliv."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijbiomac.2017.12.056","article-title":"Pramipexole Dihydrochloride Loaded Chitosan Nanoparticles for Nose to Brain Delivery: Development, Characterization and in Vivo Anti-Parkinson Activity","volume":"109","author":"Raj","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE Official Report: A Practical Clinical Definition of Epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.colsurfb.2018.11.025","article-title":"Lamotrigine Encapsulated Intra-Nasal Nanoliposome Formulation for Epilepsy Treatment: Formulation Design, Characterization and Nasal Toxicity Study","volume":"174","author":"Praveen","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s13346-019-00622-5","article-title":"Nose-to-Brain Delivery of Lamotrigine-Loaded PLGA Nanoparticles","volume":"9","author":"Nigam","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2019.04.076","article-title":"Design and Development of Letrozole Nanoemulsion: A Comparative Evaluation of Brain Targeted Nanoemulsion with Free Letrozole against Status Epilepticus and Neurodegeneration in Mice","volume":"565","author":"Iqbal","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.msec.2017.03.002","article-title":"Quality by Design Approach for an in Situ Gelling Microemulsion of Lorazepam via Intranasal Route","volume":"75","author":"Shah","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_113","first-page":"79","article-title":"Formulation Development and Characterization of Oxcarbazepine Microemulsion for Intranasal Delivery","volume":"55","author":"Tirunagari","year":"2017","journal-title":"ACTA Pharm. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"105099","DOI":"10.1016\/j.ejps.2019.105099","article-title":"Nanoemulsions and Thermosensitive Nanoemulgels of Phenytoin and Fosphenytoin for Intranasal Administration: Formulation Development and in Vitro Characterization","volume":"141","author":"Pires","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopha.2016.05.035","article-title":"Pharmacological Evidence for the Involvement of the NMDA Receptor and Nitric Oxide Pathway in the Antidepressant-like Effect of Lamotrigine in the Mouse Forced Swimming Test","volume":"82","author":"Ostadhadi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1915943","article-title":"Schizophrenia","volume":"382","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.1016\/S0924-977X(01)00111-0","article-title":"Quetiapine: Efficacy and Tolerability in Schizophrenia","volume":"11","author":"Kasper","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1208\/s12249-016-0552-9","article-title":"Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency","volume":"18","author":"Boche","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3109\/10717544.2015.1120364","article-title":"Comparative Study between Simple and Optimized Liposomal Dispersion of Quetiapine Fumarate for Diffusion through Nasal Route","volume":"23","author":"Upadhyay","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"119499","DOI":"10.1016\/j.ijpharm.2020.119499","article-title":"Preparation, Characterization, and Optimization of Asenapine Maleate Mucoadhesive Nanoemulsion Using Box-Behnken Design: In Vitro and in Vivo Studies for Brain Targeting","volume":"586","author":"Kumbhar","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/03639045.2016.1236808","article-title":"Pharmacodynamic and Pharmacokinetic Investigation of Cyclodextrin-Mediated Asenapine Maleate in Situ Nasal Gel for Improved Bioavailability","volume":"43","author":"Kulkarni","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2016.08.033","article-title":"Development of Risperidone Liposomes for Brain Targeting through Intranasal Route","volume":"163","author":"Narayan","year":"2016","journal-title":"Life Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/10717544.2014.914602","article-title":"Paliperidone Microemulsion for Nose-to-Brain Targeted Drug Delivery System: Pharmacodynamic and Pharmacokinetic Evaluation","volume":"23","author":"Patel","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12247-013-9160-3","article-title":"Paliperidone-Loaded Mucoadhesive Microemulsion in Treatment of Schizophrenia: Formulation Consideration","volume":"8","author":"Patel","year":"2013","journal-title":"J. Pharm. Innov."},{"key":"ref_125","first-page":"844","article-title":"Formulation and characterization of paliperidone loaded mucoadhesive microemulsion for intranasal delivery","volume":"8","author":"Kumar","year":"2018","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1208\/s12249-017-0844-8","article-title":"Development and Evaluation of pH-Responsive Cyclodextrin-Based in Situ Gel of Paliperidone for Intranasal Delivery","volume":"19","author":"Sherje","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/03639045.2019.1619759","article-title":"Formulation and Biopharmaceutical Evaluation of Risperidone-Loaded Chitosan Nanoparticles for Intranasal Delivery","volume":"45","author":"Rukmangathen","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biopsych.2011.08.022","article-title":"High Dimensional Endophenotype Ranking in the Search for Major Depression Risk Genes","volume":"71","author":"Glahn","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/10717544.2017.1357148","article-title":"Agomelatine-Based in Situ Gels for Brain Targeting via the Nasal Route: Statistical Optimization, in Vitro, and in Vivo Evaluation","volume":"24","author":"Fatouh","year":"2017","journal-title":"Drug Deliv."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.22270\/jddt.v9i1-s.2274","article-title":"Design Development and Evaluation of Agomelatine Microemulsion for Intranasal Delivery","volume":"9","author":"Halde","year":"2019","journal-title":"J. Drug Deliv. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Naik, A., and Nair, H. (2014). Formulation and Evaluation of Thermosensitive Biogels for Nose to Brain Delivery of Doxepin. BioMed Res. Int., 2014.","DOI":"10.1155\/2014\/847547"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"125","DOI":"10.22159\/ijpps.2018v10i6.25710","article-title":"Investigating the potential of an antidepressant intranasal mucoadhesive microemulsion","volume":"10","author":"Singh","year":"2018","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"9517","DOI":"10.2147\/IJN.S277352","article-title":"Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In Vitro Characterization, Ex Vivo Permeation, and in Vivo Biodistribution Studies","volume":"15","author":"Elsenosy","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1208\/s12249-019-1484-y","article-title":"Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery","volume":"20","author":"Khatoon","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.30827\/ars.v58i3.6528","article-title":"Quality by Design (QbD) Approach to Formulate in Situ Gelling System for Nose to Brain Delivery of Fluoxetine Hydrochloride: Ex-Vivo and In-Vivo Study","volume":"58","author":"Pathan","year":"2017","journal-title":"Ars Pharm. Internet"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"025102","DOI":"10.1088\/0957-4484\/27\/2\/025102","article-title":"Intranasal Delivery of Paroxetine Nanoemulsion via the Olfactory Region for the Management of Depression: Formulation, Behavioural and Biochemical Estimation","volume":"27","author":"Pandey","year":"2015","journal-title":"Nanotechnology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"102317","DOI":"10.1016\/j.jddst.2020.102317","article-title":"Brain Targeted Intranasal In-Situ Gelling Spray of Paroxetine: Formulation, Characterization and in-Vivo Evaluation","volume":"62","author":"Thakkar","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.carbpol.2012.02.051","article-title":"Venlafaxine Loaded Chitosan NPs for Brain Targeting: Pharmacokinetic and Pharmacodynamic Evaluation","volume":"89","author":"Haque","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.10.011","article-title":"Development and Evaluation of Brain Targeted Intranasal Alginate Nanoparticles for Treatment of Depression","volume":"48","author":"Haque","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"103569","DOI":"10.1016\/j.jddst.2022.103569","article-title":"Advanced Particulate Carrier-Mediated Technologies for Nasal Drug Delivery","volume":"74","author":"Chavda","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jri.2009.07.005","article-title":"Mucosal Immunology of the Genital and Gastrointestinal Tracts and HIV-1 Infection","volume":"83","author":"Mestecky","year":"2009","journal-title":"J. Reprod. Immunol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-1759(98)00145-8","article-title":"Intranasal Immunization with a Plant Virus Expressing a Peptide from HIV-1 Gp41 Stimulates Better Mucosal and Systemic HIV-1-Specific IgA and IgG than Oral Immunization","volume":"220","author":"Durrani","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live Attenuated Influenza Vaccine (FluMist\u00ae; Fluenz\u2122)","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.biomaterials.2011.11.068","article-title":"Thermal-Sensitive Hydrogel as Adjuvant-Free Vaccine Delivery System for H5N1 Intranasal Immunization","volume":"33","author":"Wu","year":"2012","journal-title":"Biomaterials"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1016\/j.vaccine.2015.07.023","article-title":"Restricted Replication of the Live Attenuated Influenza A Virus Vaccine during Infection of Primary Differentiated Human Nasal Epithelial Cells","volume":"33","author":"Fischer","year":"2015","journal-title":"Vaccine"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Ball, J.P., Springer, M.J., Ni, Y., Finger-Baker, I., Martinez, J., Hahn, J., Suber, J.F., DiMarco, A.V., Talton, J.D., and Cobb, R.R. (2017). Intranasal Delivery of a Bivalent Norovirus Vaccine Formulated in an in Situ Gelling Dry Powder. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177310"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2011.07.033","article-title":"Safety and Immunogenicity of an Intranasal Shigella Flexneri 2a Invaplex 50 Vaccine","volume":"29","author":"Riddle","year":"2011","journal-title":"Vaccine"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/acs.molpharmaceut.5b00707","article-title":"Intranasal Administration of Novel Chitosan Nanoparticle\/DNA Complexes Induces Antibody Response to Hepatitis B Surface Antigen in Mice","volume":"13","author":"Lebre","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Popescu, R., Ghica, M.V., Dinu-P\u00eervu, C.-E., Anu\u021ba, V., Lupuliasa, D., and Popa, L. (2020). New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145016"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3109\/02652048.2015.1073392","article-title":"Development of Chitosan\u2013Pullulan Composite Nanoparticles for Nasal Delivery of Vaccines: Optimisation and Cellular Studies","volume":"32","author":"Cevher","year":"2015","journal-title":"J. Microencapsul."},{"key":"ref_151","first-page":"100001","article-title":"Protein Delivery by Porous Cationic Maltodextrin-Based Nanoparticles into Nasal Mucosal Cells: Comparison with Cationic or Anionic Nanoparticles","volume":"1","author":"Carpentier","year":"2019","journal-title":"Int. J. Pharm. X"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nmat2784","article-title":"Nanogel Antigenic Protein-Delivery System for Adjuvant-Free Intranasal Vaccines","volume":"9","author":"Nochi","year":"2010","journal-title":"Nat. Mater."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Adam, A., Shi, Q., Wang, B., Zou, J., Mai, J., Osman, S.R., Wu, W., Xie, X., Aguilar, P.V., and Bao, X. (2021). A Modified Porous Silicon Microparticle Promotes Mucosal Delivery of SARS-CoV-2 Antigen and Induction of Potent and Durable Systemic and Mucosal T Helper 1 Skewed Protective Immunity. bioRxiv.","DOI":"10.1101\/2021.11.22.469576"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Harris, P.E., Brasel, T., Massey, C., Herst, C.V., Burkholz, S., Lloyd, P., Blankenberg, T., Bey, T.M., Carback, R., and Hodge, T. (2021). A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques. Vaccines, 9.","DOI":"10.1101\/2021.04.24.441228"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/mp200553x","article-title":"Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein","volume":"9","author":"Raghuwanshi","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-020-00434-x","article-title":"Cationic Nanocarriers as Potent Adjuvants for Recombinant S-RBD Vaccine of SARS-CoV-2","volume":"5","author":"Lei","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Jearanaiwitayakul, T., Seesen, M., Chawengkirttikul, R., Limthongkul, J., Apichirapokey, S., Sapsutthipas, S., Phumiamorn, S., Sunintaboon, P., and Ubol, S. (2021). Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2. Vaccines, 9.","DOI":"10.3390\/vaccines9070768"},{"key":"ref_158","first-page":"116","article-title":"The Dry Powder Formulation of Mixed Cross-Linked Dextran Microspheres and Tetanus Toxoid-Loaded Trimethyl Chitosan Nanospheres as a Potent Adjuvant for Nasal Delivery System","volume":"24","author":"Kabiri","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.2147\/IJN.S218456","article-title":"Simultaneous Intramuscular and Intranasal Administration of Chitosan Nanoparticles\u2013Adjuvanted Chlamydia Vaccine Elicits Elevated Protective Responses in the Lung","volume":"14","author":"Li","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Shim, S., Soh, S.H., Im, Y.B., Ahn, C., Park, H.-T., Park, H.-E., Park, W.B., Kim, S., and Yoo, H.S. (2020). Induction of Systemic Immunity through Nasal-Associated Lymphoid Tissue (NALT) of Mice Intranasally Immunized with Brucella Abortus Malate Dehydrogenase-Loaded Chitosan Nanoparticles. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0228463"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajps.2018.04.005","article-title":"Preparation, Characterization and in Vivo Evaluation of Alginate-Coated Chitosan and Trimethylchitosan Nanoparticles Loaded with PR8 Influenza Virus for Nasal Immunization","volume":"14","author":"Mosafer","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijbiomac.2020.03.065","article-title":"Chitosan, N,N,N-Trimethyl Chitosan (TMC) and 2-Hydroxypropyltrimethyl Ammonium Chloride Chitosan (HTCC): The Potential Immune Adjuvants and Nano Carriers","volume":"154","author":"Zhao","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.vaccine.2019.11.031","article-title":"An Overview of Biodegradable Nanomaterials and Applications in Vaccines","volume":"38","author":"Yan","year":"2020","journal-title":"Vaccine"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.08.032","article-title":"Rabbit Nasal Immunization against Influenza by Dry-Powder Form of Chitosan Nanospheres Encapsulated with Influenza Whole Virus and Adjuvants","volume":"475","author":"Dehghan","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"792","DOI":"10.18093\/0869-0189-2021-31-6-792-798","article-title":"Secretory immunoglobulin A of the respiratory system and COVID-19","volume":"31","author":"Kryukova","year":"2021","journal-title":"Pulmonologiya"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.drudis.2021.07.021","article-title":"Intranasal Vaccines for SARS-CoV-2: From Challenges to Potential in COVID-19 Management","volume":"26","author":"Chavda","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2012.12.013","article-title":"Biocompatibility of Engineered Nanoparticles for Drug Delivery","volume":"166","author":"Naahidi","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijbiomac.2014.08.052","article-title":"Chitosan as a Suitable Nanocarrier Material for Anti-Alzheimer Drug Delivery","volume":"72","author":"Sarvaiya","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/03639040802395185","article-title":"The Effect of Chitosan Molecular Weight on the Characteristics of Spray-Dried Methotrexate-Loaded Chitosan Microspheres for Nasal Administration","volume":"35","author":"Sun","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.addr.2012.09.022","article-title":"PEGylated Nanoparticles for Biological and Pharmaceutical Applications","volume":"64","author":"Otsuka","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Porfiryeva, N.N., Semina, I.I., Salakhov, I.A., Moustafine, R.I., and Khutoryanskiy, V.V. (2021). Mucoadhesive and Mucus-Penetrating Interpolyelectrolyte Complexes for Nose-to-Brain Drug Delivery. Nanomed. Nanotechnol. Biol. Med., 37.","DOI":"10.1016\/j.nano.2021.102432"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","article-title":"Intranasal Delivery of Nanostructured Lipid Carriers, Solid Lipid Nanoparticles and Nanoemulsions: A Current Overview of in Vivo Studies","volume":"11","author":"Costa","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.matpr.2022.06.329","article-title":"Design, Development and Optimization of Solid Lipid Nanoparticles of Rizatriptan for Intranasal Delivery: Invitro & Invivo Assessment","volume":"66","author":"Bakshi","year":"2022","journal-title":"Mater. Today Proc."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drudis.2015.10.016","article-title":"Smart Materials: In Situ Gel-Forming Systems for Nasal Delivery","volume":"21","author":"Karavasili","year":"2016","journal-title":"Drug Discov. Today"},{"key":"ref_175","first-page":"466","article-title":"Development and Evaluation of in Situ Nasal Gel Formulations of Loratadine","volume":"10","author":"Sherafudeen","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"ref_176","first-page":"103","article-title":"The main aspects of the thermorreversible polycomplexes of poloxamers developing","volume":"20","author":"Bakhrushina","year":"2018","journal-title":"J. Sci. Artic. Health Educ. Millenn."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1359-0294(02)00004-3","article-title":"Phase Structures of Microemulsions","volume":"7","author":"Hellweg","year":"2002","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"ref_178","unstructured":"Jafari, S.M., and McClements, D.J. (2018). Nanoemulsions: Formulation, Applications, and Characterization, Academic Press."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as Nanomedical Devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/anie.200301694","article-title":"Supramolecular Drug-Delivery Systems Based on Polymeric Core\u2013Shell Architectures","volume":"43","author":"Haag","year":"2004","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/anie.200502113","article-title":"Polymer Therapeutics: Concepts and Applications","volume":"45","author":"Haag","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Ray, P., Ferraro, M., Haag, R., and Quadir, M. (2019). Dendritic Polyglycerol-Derived Nano-Architectures as Delivery Platforms of Gemcitabine for Pancreatic Cancer. Macromol. Biosci., 19.","DOI":"10.1002\/mabi.201900073"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1021\/acs.molpharmaceut.5b00402","article-title":"Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer","volume":"12","author":"Katare","year":"2015","journal-title":"Mol. Pharm."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/9\/1180\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:50:15Z","timestamp":1760111415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/9\/1180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":183,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ph17091180"],"URL":"https:\/\/doi.org\/10.3390\/ph17091180","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,7]]}}}